Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Liver Imaging

Focal type of peliosis hepatis

Gil-Sun Hong, Kyoung Won Kim, Jihyun An, Ju Hyun Shim, Jihun Kim, Eun Sil Yu

Clin Mol Hepatol. 2015;21(4):398-401. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.398

View: 7282 Download: 101 Citations: 5

Case Report

A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Yeon Jung Ha, Ji Hyun An, Ju Hyun Shim, Eun Sil Yu, Jong Jae Kim, Tae Yong Ha, Han Chu Lee

Clin Mol Hepatol. 2015;21(1):80-84. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.80

View: 6935 Download: 100 Citations: 7

Original Article

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

View: 7453 Download: 120 Citations: 19

1 |

Viewed By 4109	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 2680	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2433	The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Viewed By 2405	Recent updates on the management of autoimmune hepatitis
Viewed By 2402	Management of refractory ascites

Cited By 99	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 42	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search